Medication(s)
|
Naranjo score
|
Kramer score
|
WHO score
|
---|
Biologics
|
Adalimumab
|
Possible
|
Possible
|
Possible
|
Certolizumab pegol
|
No use reported in any case report
|
Infliximab
|
Possible
|
Possible
|
Possible
|
Natalizumab
|
Possible
|
Possible
|
Possible
|
Ustekinumab
|
Possible
|
Possible
|
Possible
|
Anti-metabolites
|
6-mercaptopurine
|
Possible
|
Possible
|
Possible
|
Azathioprine
|
Possible
|
Possible
|
Possible
|
Aminosalicylates
|
Balsalazide
|
Possible
|
Unlikely
|
Possible
|
Mesalamine
|
Possible
|
Unlikely
|
Possible
|
Sulfasalazine
|
Possible
|
Unlikely
|
Possible
|
Corticosteroids
|
Budesonide
|
Possible
|
Unlikely
|
Possible
|
Hydrocortisone
|
Possible
|
Unlikely
|
Possible
|
Prednisone
|
Possible
|
Unlikely
|
Possible
|
Prednisolone
|
Possible
|
Unlikely
|
Possible
|
Corticosteroid unspecified
|
Possible
|
Unlikely
|
Possible
|
Other medications
|
Cyclosporine
|
Possible
|
Possible
|
Possible
|
Metronidazole
|
Possible
|
Unlikely
|
Possible
|
Nitrofurantoin
|
Possible
|
Unlikely
|
Possible
|
Piperacillin/tazobactam
|
Possible
|
Unlikely
|
Possible
|
Doxycycline
|
Possible
|
Unlikely
|
Possible
|
Ciprofloxacin
|
Possible
|
Unlikely
|
Possible
|
- Possible, all cases reporting that medication received a score of ‘possible’ using that particular causality assessment; unlikely, all cases reporting that medication received a score of ‘unlikely’ using that particular causality assessment. WHO, World Health Organization.